Avrobio Inc (AVRO)
1.21
+0.02
(+2.11%)
USD |
NASDAQ |
Apr 26, 16:00
1.21
0.00 (0.00%)
After-Hours: 16:43
Avrobio Total Liabilities (Quarterly): 6.354M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.354M |
| September 30, 2023 | 7.664M |
| June 30, 2023 | 11.80M |
| March 31, 2023 | 30.01M |
| December 31, 2022 | 28.58M |
| September 30, 2022 | 31.41M |
| June 30, 2022 | 27.90M |
| March 31, 2022 | 32.18M |
| December 31, 2021 | 34.36M |
| September 30, 2021 | 22.88M |
| June 30, 2021 | 17.10M |
| March 31, 2021 | 12.98M |
| December 31, 2020 | 16.89M |
| Date | Value |
|---|---|
| September 30, 2020 | 25.38M |
| June 30, 2020 | 15.78M |
| March 31, 2020 | 13.20M |
| December 31, 2019 | 14.50M |
| September 30, 2019 | 10.44M |
| June 30, 2019 | 9.355M |
| March 31, 2019 | 10.58M |
| December 31, 2018 | 11.30M |
| September 30, 2018 | 6.163M |
| June 30, 2018 | 10.41M |
| March 31, 2018 | 6.18M |
| December 31, 2017 | 30.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.354M
Minimum
Dec 2023
34.36M
Maximum
Dec 2021
19.41M
Average
16.89M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| Axonics Inc | 82.36M |
| Catalent Inc | 6.301B |
| AIM ImmunoTech Inc | 9.147M |
| Protalix BioTherapeutics Inc | 50.86M |
| Armata Pharmaceuticals Inc | 130.43M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 101.09M |
| Shareholders Equity (Quarterly) | 94.74M |